Grifols

Infobox_Company
company_name = Grifols SA
company_
company_type = Public (BMAD|ES0171996012|GRF)
foundation = 1940
location = Barcelona, Spain
key_people = Victor Grifols(Chairman)
industry = Pharma, chemistry
products = pharmaceuticals
num_employees = -
revenue = €648.8 million (2006)
net_income = profit €45.4 million (2006)
homepage = [http://www.grifols.com www.grifols.com]
intl = yes

Grifols (BMAD|ES0171996012|GRF) is a Spanish supplier of blood products. The company also supplies devices, instruments and reagents for clinical testing laboratories.

Main products

Grifols is a major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products.

Main operations

In 2007 the company had 3.6 million litres per year of blood fractionation capacity from two plants, one at Parets del Vallès near Barcelona in Spain (2.1 million litres per year) and another in Los Angeles (1.5 million litres but being expanded to 2.2 million litres). In the United States the company owns 77 plasmapheresis centres, where it collects around 2 million litres of plasma per year.

Ownership

Grifols was listed on the Madrid Stock Exchange in 2006. The stock became part of the IBEX-35 Index in January 2008.

History

Grifols was founded in 1940 by Dr J. A. Grifols Roig, a hematologist and scientist. The company introduced its liquid IVIG product into the European market in the mid-1990s. In 2003 the company acquired certain assets of the Los Angeles-based Alpha Therapeutic as the basis of its American expansion.

References

*http://www.grifols.es/web/presskit/documento_5575.pdf

External links

* [http://www.grifols.com Official website]